{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T13:45:14Z","timestamp":1791380714798,"version":"4.3.3"},"reference-count":49,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T00:00:00Z","timestamp":1691539200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173136"],"award-info":[{"award-number":["82173136"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,1,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Approximately 35% of pituitary adenoma (PA) display an aggressive profile, resulting in low surgical total resection rates, high recurrence rates, and worse prognosis. However, the molecular mechanism of PA invasion remains poorly understood. Although \u201ca disintegrin and metalloproteinases\u201d (ADAMs) are associated with the progression of many tumors, there are no reports on ADAM22 in PA.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>PA transcriptomics databases and clinical specimens were used to analyze the expression of ADAM22. PA cell lines overexpressing wild-type ADAM22, the point mutation ADAM22, the mutated ADAM22 without disintegrin domain, and knocking down ADAM22 were generated. Cell proliferation\/invasion assays, flow cytometry, immunohistochemistry, immunofluorescence, co-immunoprecipitation, mass spectrometry, Reverse transcription-quantitative real-time PCR, phos-tag SDS-PAGE, and Western blot were performed for function and mechanism research. Nude mice xenograft models and rat prolactinoma orthotopic models were used to validate in vitro findings.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>ADAM22 was significantly overexpressed in PA and could promote the proliferation, migration, and invasion of PA cells. ADAM22 interacted with integrin \u03b21 (ITGB1) and activated FAK\/PI3K and FAK\/ERK signaling pathways through its disintegrin domain to promote PA progression. ADAM22 was phosphorylated by PKA and recruited 14-3-3, thereby delaying its degradation. ITGB1-targeted inhibitor (anti-itgb1) exerted antitumor effects and synergistic effects in combination with somatostatin analogs or dopamine agonists in treating PA.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>ADAM22 was upregulated in PA and was able to promote PA proliferation, migration, and invasion by activating ITGB1 signaling. PKA may regulate the degradation of ADAM22 through post-transcriptional modification levels. ITGB1 may be a potential therapeutic target for PA.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/neuonc\/noad148","type":"journal-article","created":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T12:37:19Z","timestamp":1691498239000},"page":"137-152","source":"Crossref","is-referenced-by-count":13,"title":["A disintegrin and metalloproteinase 22 activates integrin <b>\u03b2<\/b>1 through its disintegrin domain to promote the progression of pituitary adenoma"],"prefix":"10.1093","volume":"26","author":[{"given":"Biao","family":"Xing","sequence":"first","affiliation":[{"name":"Sino-German Neuro-Oncology Molecular Laboratory, Department of Neurosurgery, Tongji Hospital of Tongji medical college of Huazhong University of Science and Technology , Wuhan , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuowei","family":"Lei","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, Tongji Hospital of Tongji medical college of Huazhong University of Science and Technology , Wuhan , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihan","family":"Wang","sequence":"additional","affiliation":[{"name":"Sino-German Neuro-Oncology Molecular Laboratory, Department of Neurosurgery, Tongji Hospital of Tongji medical college of Huazhong University of Science and Technology , Wuhan , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quanji","family":"Wang","sequence":"additional","affiliation":[{"name":"Sino-German Neuro-Oncology Molecular Laboratory, Department of Neurosurgery, Tongji Hospital of Tongji medical college of Huazhong University of Science and Technology , Wuhan , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Jiang","sequence":"additional","affiliation":[{"name":"Sino-German Neuro-Oncology Molecular Laboratory, Department of Neurosurgery, Tongji Hospital of Tongji medical college of Huazhong University of Science and Technology , Wuhan , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuo","family":"Zhang","sequence":"additional","affiliation":[{"name":"Sino-German Neuro-Oncology Molecular Laboratory, Department of Neurosurgery, Tongji Hospital of Tongji medical college of Huazhong University of Science and Technology , Wuhan , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojin","family":"Liu","sequence":"additional","affiliation":[{"name":"Sino-German Neuro-Oncology Molecular Laboratory, Department of Neurosurgery, Tongji Hospital of Tongji medical college of Huazhong University of Science and Technology , Wuhan , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiwei","family":"Qi","sequence":"additional","affiliation":[{"name":"Sino-German Neuro-Oncology Molecular Laboratory, Department of Neurosurgery, Tongji Hospital of Tongji medical college of Huazhong University of Science and Technology , Wuhan , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sihan","family":"Li","sequence":"additional","affiliation":[{"name":"Sino-German Neuro-Oncology Molecular Laboratory, Department of Neurosurgery, Tongji Hospital of Tongji medical college of Huazhong University of Science and Technology , Wuhan , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Guo","sequence":"additional","affiliation":[{"name":"Sino-German Neuro-Oncology Molecular Laboratory, Department of Neurosurgery, Tongji Hospital of Tongji medical college of Huazhong University of Science and Technology , Wuhan , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanchao","family":"Liu","sequence":"additional","affiliation":[{"name":"Sino-German Neuro-Oncology Molecular Laboratory, Department of Neurosurgery, Tongji Hospital of Tongji medical college of Huazhong University of Science and Technology , Wuhan , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingbo","family":"Li","sequence":"additional","affiliation":[{"name":"Sino-German Neuro-Oncology Molecular Laboratory, Department of Neurosurgery, Tongji Hospital of Tongji medical college of Huazhong University of Science and Technology , Wuhan , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Shu","sequence":"additional","affiliation":[{"name":"Sino-German Neuro-Oncology Molecular Laboratory, Department of Neurosurgery, Tongji Hospital of Tongji medical college of Huazhong University of Science and Technology , Wuhan , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaqiu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Sino-German Neuro-Oncology Molecular Laboratory, Department of Neurosurgery, Tongji Hospital of Tongji medical college of Huazhong University of Science and Technology , Wuhan , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg Walter","family":"Bartsch","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Philipps-University Marburg, University Hospital Marburg (UKGM) , Marburg , Germany"},{"name":"Center for Mind, Brain and Behavior (CMBB) , Marburg , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Nimsky","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Philipps-University Marburg, University Hospital Marburg (UKGM) , Marburg , Germany"},{"name":"Center for Mind, Brain and Behavior (CMBB) , Marburg , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yimin","family":"Huang","sequence":"additional","affiliation":[{"name":"Sino-German Neuro-Oncology Molecular Laboratory, Department of Neurosurgery, Tongji Hospital of Tongji medical college of Huazhong University of Science and Technology , Wuhan , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Lei","sequence":"additional","affiliation":[{"name":"Sino-German Neuro-Oncology Molecular Laboratory, Department of Neurosurgery, Tongji Hospital of Tongji medical college of Huazhong University of Science and Technology , Wuhan , China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,8,9]]},"reference":[{"key":"2024010518140866000_CIT0001","doi-asserted-by":"crossref","first-page":"v1","DOI":"10.1093\/neuonc\/noac202","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2015-2019","volume":"24","author":"Ostrom","year":"2022","journal-title":"Neuro Oncol"},{"issue":"6","key":"2024010518140866000_CIT0002","doi-asserted-by":"crossref","first-page":"733","DOI":"10.3171\/jns.1986.65.6.0733","article-title":"Pathology of invasive pituitary tumors with special reference to functional classification","volume":"65","author":"Scheithauer","year":"1986","journal-title":"J Neurosurg."},{"issue":"9","key":"2024010518140866000_CIT0003","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.3390\/jcm11092464","article-title":"Classifying pituitary adenoma invasiveness based on radiological, surgical and histological features: A retrospective assessment of 903 cases","volume":"11","author":"Lu","year":"2022","journal-title":"J Clin Med"},{"issue":"11","key":"2024010518140866000_CIT0004","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/s41574-021-00550-w","article-title":"Aggressive pituitary tumours and pituitary carcinomas","volume":"17","author":"Raverot","year":"2021","journal-title":"Nat Rev Endocrinol."},{"issue":"1","key":"2024010518140866000_CIT0005","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s00401-013-1084-y","article-title":"A new prognostic clinicopathological classification of pituitary adenomas: A multicentric case-control study of 410 patients with 8 years post-operative follow-up","volume":"126","author":"Trouillas","year":"2013","journal-title":"Acta Neuropathol."},{"issue":"4","key":"2024010518140866000_CIT0006","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.3892\/ol.2016.5029","article-title":"Whole-exome sequencing identifies variants in invasive pituitary adenomas","volume":"12","author":"Lan","year":"2016","journal-title":"Oncol Lett"},{"issue":"6","key":"2024010518140866000_CIT0007","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1210\/endrev\/bnaa006","article-title":"Novel insights into pituitary tumorigenesis: Genetic and epigenetic mechanisms","volume":"41","author":"Srirangam Nadhamuni","year":"2020","journal-title":"Endocr Rev."},{"issue":"5","key":"2024010518140866000_CIT0008","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.mam.2008.08.001","article-title":"The ADAM metalloproteinases","volume":"29","author":"Edwards","year":"2008","journal-title":"Mol Aspects Med."},{"issue":"4","key":"2024010518140866000_CIT0009","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3390\/toxins8040122","article-title":"A Disintegrin and Metalloprotease (ADAM): Historical overview of their functions","volume":"8","author":"Giebeler","year":"2016","journal-title":"Toxins (Basel)"},{"issue":"16","key":"2024010518140866000_CIT0010","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1007\/s00018-019-03173-7","article-title":"Functions of \u201cA disintegrin and metalloproteases (ADAMs)\u201d in the mammalian nervous system","volume":"76","author":"Hsia","year":"2019","journal-title":"Cell Mol Life Sci."},{"issue":"11","key":"2024010518140866000_CIT0011","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1093\/neuonc\/nov042","article-title":"The metalloprotease-disintegrin ADAM8 contributes to temozolomide chemoresistance and enhanced invasiveness of human glioblastoma cells","volume":"17","author":"Dong","year":"2015","journal-title":"Neuro Oncol"},{"issue":"19","key":"2024010518140866000_CIT0012","doi-asserted-by":"crossref","first-page":"4910","DOI":"10.3390\/cancers14194910","article-title":"The GBM tumor microenvironment as a modulator of therapy response: ADAM8 causes tumor infiltration of tams through HB-EGF\/EGFR-Mediated CCL2 expression and overcomes TMZ chemosensitization in glioblastoma","volume":"14","author":"Liu","year":"2022","journal-title":"Cancers (Basel)"},{"key":"2024010518140866000_CIT0013","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.biopha.2017.11.034","article-title":"ADAM12 induces EMT and promotes cell migration, invasion and proliferation in pituitary adenomas via EGFR\/ERK signaling pathway","volume":"97","author":"Wang","year":"2018","journal-title":"Biomed Pharmacother."},{"issue":"5794","key":"2024010518140866000_CIT0014","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1126\/science.1129947","article-title":"Epilepsy-related ligand\/receptor complex LGI1 and ADAM22 regulate synaptic transmission","volume":"313","author":"Fukata","year":"2006","journal-title":"Science."},{"issue":"11","key":"2024010518140866000_CIT0015","doi-asserted-by":"crossref","first-page":"110107","DOI":"10.1016\/j.celrep.2021.110107","article-title":"14-3-3 proteins stabilize LGI1-ADAM22 levels to regulate seizure thresholds in mice","volume":"37","author":"Yokoi","year":"2021","journal-title":"Cell Rep"},{"issue":"1","key":"2024010518140866000_CIT0016","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1038\/s41467-018-03947-w","article-title":"Structural basis of epilepsy-related ligand-receptor complex LGI1-ADAM22","volume":"9","author":"Yamagata","year":"2018","journal-title":"Nat Commun."},{"key":"2024010518140866000_CIT0017","doi-asserted-by":"crossref","first-page":"ed2005","DOI":"10.1186\/1471-2202-6-33","article-title":"Ataxia and peripheral nerve hypomyelination in ADAM22-deficient mice","volume":"6","author":"Sagane","year":"2005","journal-title":"BMC Neurosci."},{"issue":"6","key":"2024010518140866000_CIT0018","doi-asserted-by":"crossref","first-page":"387","DOI":"10.7150\/ijbs.4.387","article-title":"LGI1 and LGI4 bind to ADAM22, ADAM23 and ADAM11","volume":"4","author":"Sagane","year":"2008","journal-title":"Int J Biol Sci."},{"key":"2024010518140866000_CIT0019","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/B978-0-12-416673-8.00014-9","article-title":"ADAM22 as a prognostic and therapeutic drug target in the treatment of endocrine-resistant breast cancer","volume":"93","author":"Bolger","year":"2013","journal-title":"Vitam Horm."},{"issue":"1","key":"2024010518140866000_CIT0020","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1158\/0008-5472.CAN-11-1976","article-title":"Global characterization of the SRC-1 transcriptome identifies ADAM22 as an ER-independent mediator of endocrine-resistant breast cancer","volume":"72","author":"McCartan","year":"2012","journal-title":"Cancer Res."},{"issue":"1","key":"2024010518140866000_CIT0021","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1186\/s12916-020-01806-4","article-title":"ADAM22\/LGI1 complex as a new actionable target for breast cancer brain metastasis","volume":"18","author":"Charmsaz","year":"2020","journal-title":"BMC Med."},{"issue":"3","key":"2024010518140866000_CIT0022","doi-asserted-by":"crossref","first-page":"a004994","DOI":"10.1101\/cshperspect.a004994","article-title":"Integrin structure, activation, and interactions","volume":"3","author":"Campbell","year":"2011","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"1","key":"2024010518140866000_CIT0023","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-022-01259-6","article-title":"Targeting integrin pathways: Mechanisms and advances in therapy","volume":"8","author":"Pang","year":"2023","journal-title":"Signal Transduct Target Ther"},{"issue":"13","key":"2024010518140866000_CIT0024","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1007\/s00018-018-2796-x","article-title":"The pleiotropic roles of ADAM9 in the biology of solid tumors","volume":"75","author":"Oria","year":"2018","journal-title":"Cell Mol Life Sci."},{"issue":"5","key":"2024010518140866000_CIT0025","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/s41419-022-04928-0","article-title":"Integrin alpha3\/alpha6 and alphaV are implicated in ADAM15-activated FAK and EGFR signalling pathway individually and promote non-small-cell lung cancer progression","volume":"13","author":"Zhou","year":"2022","journal-title":"Cell Death Dis."},{"key":"2024010518140866000_CIT0026","doi-asserted-by":"crossref","first-page":"6175","DOI":"10.1038\/ncomms7175","article-title":"ADAM8 as a drug target in pancreatic cancer","volume":"6","author":"Schlomann","year":"2015","journal-title":"Nat Commun."},{"issue":"2","key":"2024010518140866000_CIT0027","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.yexcr.2018.06.039","article-title":"ADAM17 promotes cell migration and invasion through the integrin beta1 pathway in hepatocellular carcinoma","volume":"370","author":"Li","year":"2018","journal-title":"Exp Cell Res."},{"issue":"3","key":"2024010518140866000_CIT0028","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s11060-013-1351-8","article-title":"Effects of the estrogen receptor antagonist fulvestrant on F344 rat prolactinoma models","volume":"116","author":"Cao","year":"2014","journal-title":"J Neurooncol."},{"issue":"1","key":"2024010518140866000_CIT0029","first-page":"154","article-title":"Characterization of integrin receptors in normal and neoplastic human brain","volume":"143","author":"Paulus","year":"1993","journal-title":"Am J Pathol."},{"issue":"1","key":"2024010518140866000_CIT0030","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/hep.27402","article-title":"FAK is required for c-Met\/beta-catenin-driven hepatocarcinogenesis","volume":"61","author":"Shang","year":"2015","journal-title":"Hepatology."},{"issue":"14","key":"2024010518140866000_CIT0031","doi-asserted-by":"crossref","first-page":"5575","DOI":"10.7150\/ijbs.70504","article-title":"A novel methylated cation channel TRPM4 inhibited colorectal cancer metastasis through Ca(2+)\/Calpain-mediated proteolysis of FAK and suppression of PI3K\/Akt\/mTOR signaling pathway","volume":"18","author":"Wang","year":"2022","journal-title":"Int J Biol Sci."},{"issue":"7","key":"2024010518140866000_CIT0032","first-page":"2077","article-title":"Biochemical characteristics of human pituitary somatotropinomas with and without gsp mutations: In vitro cell culture studies","volume":"80","author":"Adams","year":"1995","journal-title":"J Clin Endocrinol Metab."},{"issue":"3","key":"2024010518140866000_CIT0033","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/j.1750-3639.2001.tb00403.x","article-title":"Oncogene activation in pituitary tumors","volume":"11","author":"Yu","year":"2001","journal-title":"Brain Pathol."},{"issue":"3","key":"2024010518140866000_CIT0034","first-page":"569","article-title":"Relationship between protein kinase C and adenylyl cyclase activity in the regulation of growth hormone secretion by human pituitary somatotrophinomas","volume":"39","author":"Lei","year":"1996","journal-title":"Neurosurgery."},{"key":"2024010518140866000_CIT0035","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.lfs.2017.11.040","article-title":"Increase in Ca(2+) current by sustained cAMP levels enhances proliferation rate in GH3 cells","volume":"192","author":"Rodrigues","year":"2018","journal-title":"Life Sci."},{"issue":"4","key":"2024010518140866000_CIT0036","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.bbrc.2005.03.229","article-title":"ADAM22 plays an important role in cell adhesion and spreading with the assistance of 14-3-3","volume":"331","author":"Zhu","year":"2005","journal-title":"Biochem Biophys Res Commun."},{"issue":"4","key":"2024010518140866000_CIT0037","first-page":"577","article-title":"Forward transport. 14-3-3 binding overcomes retention in endoplasmic reticulum by dibasic signals","volume":"111","author":"O\u2019Kelly","year":"2002","journal-title":"Cell."},{"issue":"Pt 16","key":"2024010518140866000_CIT0038","doi-asserted-by":"crossref","first-page":"3296","DOI":"10.1242\/jcs.03065","article-title":"Efficient ADAM22 surface expression is mediated by phosphorylation-dependent interaction with 14-3-3 protein family members","volume":"119","author":"Godde","year":"2006","journal-title":"J Cell Sci."},{"issue":"12","key":"2024010518140866000_CIT0039","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1038\/s41419-021-04451-8","article-title":"Aldehyde dehydrogenase 3B2 promotes the proliferation and invasion of cholangiocarcinoma by increasing Integrin Beta 1 expression","volume":"12","author":"Wang","year":"2021","journal-title":"Cell Death Dis."},{"key":"2024010518140866000_CIT0040","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.canlet.2018.05.004","article-title":"CD31 regulates metastasis by inducing epithelial-mesenchymal transition in hepatocellular carcinoma via the ITGB1-FAK-Akt signaling pathway","volume":"429","author":"Zhang","year":"2018","journal-title":"Cancer Lett."},{"issue":"1","key":"2024010518140866000_CIT0041","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1158\/0008-5472.CAN-13-1742","article-title":"beta1 integrin: Critical path to antiangiogenic therapy resistance and beyond","volume":"74","author":"Jahangiri","year":"2014","journal-title":"Cancer Res."},{"issue":"1","key":"2024010518140866000_CIT0042","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3390\/pharmaceutics13010040","article-title":"Convection-enhanced delivery of a first-in-class anti-beta1 integrin antibody for the treatment of high-grade glioma utilizing real-time imaging","volume":"13","author":"Nwagwu","year":"2020","journal-title":"Pharmaceutics"},{"issue":"12","key":"2024010518140866000_CIT0043","doi-asserted-by":"crossref","first-page":"e138928","DOI":"10.1172\/jci.insight.138928","article-title":"Role of c-Met\/beta1 integrin complex in the metastatic cascade in breast cancer","volume":"6","author":"Lau","year":"2021","journal-title":"JCI Insight"},{"issue":"2","key":"2024010518140866000_CIT0044","doi-asserted-by":"crossref","first-page":"833","DOI":"10.7150\/thno.77441","article-title":"ALKBH5 activates FAK signaling through m6A demethylation in ITGB1 mRNA and enhances tumor-associated lymphangiogenesis and lymph node metastasis in ovarian cancer","volume":"13","author":"Sun","year":"2023","journal-title":"Theranostics"},{"key":"2024010518140866000_CIT0045","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.atherosclerosis.2019.02.002","article-title":"A disintegrin and metalloprotease 22 accelerates neointima formation by activating ERK signaling","volume":"283","author":"Zhang","year":"2019","journal-title":"Atherosclerosis."},{"issue":"1","key":"2024010518140866000_CIT0046","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1227\/01.NEU.0000192363.84287.8B","article-title":"ADAM22, expressed in normal brain but not in high-grade gliomas, inhibits cellular proliferation via the disintegrin domain","volume":"58","author":"D\u2019Abaco","year":"2006","journal-title":"Neurosurgery."},{"issue":"Pt A","key":"2024010518140866000_CIT0047","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.phrs.2016.08.004","article-title":"Integrins in glioblastoma: Still an attractive target","volume":"113","author":"Paolillo","year":"2016","journal-title":"Pharmacol Res."},{"issue":"6","key":"2024010518140866000_CIT0048","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.trsl.2014.12.006","article-title":"CXCL12 and ADAM23 hypermethylation are associated with advanced breast cancers","volume":"165","author":"Fridrichova","year":"2015","journal-title":"Transl Res."},{"issue":"5","key":"2024010518140866000_CIT0049","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1189\/jlb.2HI1115-525R","article-title":"Dendritic cell expression of ADAM23 governs T cell proliferation and cytokine production through the alpha(v)beta(3) integrin receptor","volume":"100","author":"Elizondo","year":"2016","journal-title":"J Leukoc Biol."}],"container-title":["Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/advance-article-pdf\/doi\/10.1093\/neuonc\/noad148\/51683872\/noad148.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/26\/1\/137\/55117534\/noad148.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/26\/1\/137\/55117534\/noad148.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T18:15:32Z","timestamp":1704478532000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article\/26\/1\/137\/7239911"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,9]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,8,9]]},"published-print":{"date-parts":[[2024,1,5]]}},"URL":"https:\/\/doi.org\/10.1093\/neuonc\/noad148","relation":{},"ISSN":["1522-8517","1523-5866"],"issn-type":[{"value":"1522-8517","type":"print"},{"value":"1523-5866","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,1,1]]},"published":{"date-parts":[[2023,8,9]]}}}